These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32825816)

  • 21. [Ethical considerations during health crisis: about SARS-CoV-2 coronavirus pandemic.].
    Santillán-García A; Ferrer-Arnedo C
    Rev Esp Salud Publica; 2020 Nov; 94():. PubMed ID: 33154346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial.
    McMahon JH; Lau JSY; Roney J; Rogers BA; Trubiano J; Sasadeusz J; Molton JS; Gardiner B; Lee SJ; Hoy JF; Cheng A; Peleg AY
    Trials; 2020 Oct; 21(1):847. PubMed ID: 33050947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
    Li J; Zhang C; Wu Z; Wang G; Zhao H
    Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
    Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.
    Bosi E; Bosi C; Rovere Querini P; Mancini N; Calori G; Ruggeri A; Canzonieri C; Callegaro L; Clementi M; De Cobelli F; Filippi M; Bregni M
    Trials; 2020 Nov; 21(1):939. PubMed ID: 33225960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation].
    Xu Q; Jiang X; Wang T; Zhou Q; Wang J; Zhang P; Yang S; Yan H; Tao X; Lu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):430-434. PubMed ID: 32527347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Audio Interview: Caring for Patients with Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Apr; 382(16):e50. PubMed ID: 32294372
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review on Repurposing Use of Favipiravir Against SARS-CoV-2.
    Nasir M; Perveen RA; Saha SK; Talha KA; Selina F; Islam MA
    Mymensingh Med J; 2020 Jul; 29(3):747-754. PubMed ID: 32844821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.
    Sigfrid L; Maskell K; Bannister PG; Ismail SA; Collinson S; Regmi S; Blackmore C; Harriss E; Longuere KS; Gobat N; Horby P; Clarke M; Carson G
    BMC Med; 2020 Jun; 18(1):190. PubMed ID: 32586391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
    Davies M; Osborne V; Lane S; Roy D; Dhanda S; Evans A; Shakir S
    Drug Saf; 2020 Jul; 43(7):645-656. PubMed ID: 32468196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations.
    Dawoud DM; Soliman KY
    Value Health; 2020 Nov; 23(11):1409-1422. PubMed ID: 33127010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
    Zhong H; Wang Y; Zhang ZL; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Pharmacol Res; 2020 Jul; 157():104872. PubMed ID: 32360583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicines for the Treatment Of COVID-19: Awaiting the Evidence.
    Marto N; Monteiro EC
    Acta Med Port; 2020 Jul; 33(7-8):500-504. PubMed ID: 32425152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 39. The UK hibernated pandemic influenza research portfolio: triggered for COVID-19.
    Simpson CR; Thomas BD; Challen K; De Angelis D; Fragaszy E; Goodacre S; Hayward A; Lim WS; Rubin GJ; Semple MG; Knight M;
    Lancet Infect Dis; 2020 Jul; 20(7):767-769. PubMed ID: 32422199
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug interactions with potential antivirals used for COVID-19 in older persons.
    Ho V; Tee C; See KC
    Geriatr Gerontol Int; 2020 Jul; 20(7):737-739. PubMed ID: 32691927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.